Evidence map›Paper›PMID 34773601›Full record

ArticleJournal of nephrology2022

Contraceptive use among women with kidney transplants in the United States.

Silvi Shah, Annette L Christianson, Shalini Bumb, Prasoon Verma

Open access · hybridAbstract read
In one paragraph

Article in Journal of nephrology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Contraceptive Use and Reproductive Health in Women With CKD: A Qualitative Study of Nephrologists in the United States.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2026
    Article
  3. Article
  4. Kidney disease and reproductive health.Nature reviews. Nephrology · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Overturning Roe Will Do Harm to Our Patients.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Silvi ShahDivision of Nephrology, Kidney C.A.R.E. (Clinical Advancement, Research and Education) Program, University of Cincinnati, 231 Albert Sabin Way, MSB 6112, Cincinnati, OH, 45267, USA. shah2sv@ucmail.uc.edu.
Annette L ChristiansonDepartment of Environmental Health, University of Cincinnati, Cincinnati, OH, USA.
Shalini BumbDivision of Nephrology, Kidney C.A.R.E. (Clinical Advancement, Research and Education) Program, University of Cincinnati, 231 Albert Sabin Way, MSB 6112, Cincinnati, OH, 45267, USA.
Prasoon VermaCincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Sabin Vaccine Institute · USCincinnati Children's Hospital Medical Center · USUniversity of Cincinnati · US

Funding

Sex Disparities in Cardiovascular Disease and Optimal Coronary Revascularization in Dialysis PatientsK23HL151816 · NHLBI · UNIVERSITY OF CINCINNATI · PI SHAH, SILVI · 2021 to 2025
$1.0M
NHLBI NIH HHS 1K23HL151816-01A1NHLBI NIH HHS K23 HL151816
6 · The paper itself

Abstract

backgroundKidney transplant improves reproductive function in women with end-stage kidney disease. Little is known about contraceptive use in women with history of kidney transplants.

methodsUsing data from the United States Renal Data System, we evaluated for each calendar year women with kidney transplantation between 1/1/2005 and 12/31/2013 who were aged 15-44 years with Medicare as the primary payer and linked data from the United Network for Organ Sharing, for up to three entire years after the date of transplantation. We determined rates of contraceptive use and used multivariable logistic regression to identify factors associated with contraceptive use.

resultsThe study cohort included 13,150 women and represented 26,624 person-years. The rate of contraceptive use was 9.5%. Compared to women aged 15-24 years, contraceptive use was lower in women aged 30-34 years (OR 0.67; CI 0.58-0.78), 35-39 years (OR 0.36; CI 0.31-0.43), and 40-44 years (OR 0.23; CI 0.19-0.28). Compared to white women, contraceptive use was higher both in black women (OR 1.26; CI 1.10-1.43) and Native American women (OR 1.52; CI 1.02-2.26). Women had lower rates of contraceptive use in the second-year post-transplant (OR 0.87; CI 0.79-0.94) and the third-year post-transplant (OR0.69; CI 0.62-0.76) than in the first-year post-transplant. Women with a history of diabetes had a lower likelihood of contraceptive use (OR 0.80; CI 0.65-0.99).

conclusionAmong women with kidney transplants, contraceptive use remains low at 9.5%. Factors associated with a higher likelihood of contraceptive use include younger age and black and Native American race/ethnicity; and second- and third-year post-transplant. The history of diabetes is associated with a lower likelihood of contraceptive use. The study highlights the need of increasing awareness for safe and effective contraceptive use in women with kidney transplants.

Indexed as

Kidney Failure, ChronicKidney TransplantationAdolescentAdultAgedContraceptive AgentsEthnicityFemaleHumansMedicareUnited StatesYoung AdultContraceptive AgentsContraceptionKidney transplantRace/ethnicityRates

Identifiers

PMID34773601
PMCPMC8926989
OpenAlexW3213766936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.